With reference to its intimation dated May 31, 2022 regarding Earnings Presentation for Quarter 4- Financial Year 2021-2022, Fermenta Biotech has informed that there was a typographical error on page 6 – para 2 ‘Q4-FY22 Operational Highlights’ of the said Earnings Presentation. In view of above, the company has enclosed the revised Earnings Presentation for Quarter 4- Financial Year 2021-2022 for the record. Except the said revision on page 6- para 2 ‘Q4-FY22 Operational Highlights’, all other details remain unchanged. The revised Earnings Presentation will thereafter be uploaded on Company’s website at www.fermentabiotech.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: